| 12054551 |
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides |
Mark Sommerfeld, Thomas LANGER, Uwe Schwahn, Werner DITTRICH, Christine RUDOLPH +3 more |
2024-08-06 |
$17,149,000 |
| 10806797 |
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate |
Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Pradeep K. Dhal +7 more |
2020-10-20 |
$20,781,000 |
| 10538567 |
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists |
Martin Bossart, Andreas Evers, Torsten Haack, Dieter Kadereit, Michael Wagner +2 more |
2020-01-21 |
$21,956,000 |
| 10519211 |
Compounds as peptidic GLP1/glucagon/GIP receptor agonists |
Martin Bossart, Andreas Evers, Torsten Haack, Dieter Kadereit, Michael Wagner +2 more |
2019-12-31 |
$5,348,000 |
| 10253079 |
Functionalized Exendin-4 derivatives |
Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers +1 more |
2019-04-09 |
$12,447,000 |
| 9982029 |
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists |
Martin Bossart, Andreas Evers, Torsten Haack, Dieter Kadereit, Michael Wagner +1 more |
2018-05-29 |
$11,844,000 |
| 9884860 |
Fused pyrroledicarboxamides and their use as pharmaceuticals |
Laurent Bialy, Klaus Wirth, Klaus Steinmeyer, Gerhard Hessler |
2018-02-06 |
$9,384,000 |
| 9789165 |
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists |
Dieter Kadereit, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more |
2017-10-17 |
$7,245,000 |
| 9776991 |
Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase |
Maria MENDEZ-PEREZ, Kristin Breitschopf, Hartmut Strobel, Li Wang, Alexander Schiffer +1 more |
2017-10-03 |
$8,333,000 |
| 9771406 |
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 |
Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin +1 more |
2017-09-26 |
$18,404,000 |
| 9751926 |
Dual GLP-1/GIP receptor agonists |
Dieter Kadereit, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more |
2017-09-05 |
$7,330,000 |
| 9750788 |
Non-acylated exendin-4 peptide analogues |
Dieter Kadereit, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more |
2017-09-05 |
$7,330,000 |
| 9745360 |
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists |
Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers +1 more |
2017-08-29 |
$18,132,000 |
| 9670261 |
Functionalized exendin-4 derivatives |
Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers +1 more |
2017-06-06 |
$14,464,000 |
| 9598410 |
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
Laurent Bialy, Klaus Wirth, Klaus Steinmeyer, Gerhard Hessler, Josef Pernerstorfer +1 more |
2017-03-21 |
$7,741,000 |
| 9540391 |
Isomannide derivatives as inhibitors of soluble epoxide hydrolase |
Kristin Breitschopf, Hartmut Strobel, Maria MENDEZ-PEREZ, Li Wang, Alexander Schiffer +3 more |
2017-01-10 |
$18,372,000 |
| 9284333 |
Fused pyrroledicarboxamides and their use as pharmaceuticals |
Laurent Bialy, Klaus Wirth, Klaus Steinmeyer, Gerhard Hessler |
2016-03-15 |
$12,021,000 |
| 9127001 |
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
Laurent Bialy, Klaus Wirth, Klaus Steinmeyer, Gerhard Hessler, Josef Pernerstorfer +1 more |
2015-09-08 |
$13,064,000 |
| 8772492 |
Substituted isoquinoline and isoquinolinone derivatives |
Oliver Plettenburg, Jochen Goerlitzer, Matthias Löhn |
2014-07-08 |
$25,739,000 |
| 8742116 |
Cycloalkylamine substituted isoquinolone derivatives |
Oliver Plettenburg, Armin Hofmeister, Joachim Brendel, Matthias Löhn, John Weston |
2014-06-03 |
$19,103,000 |
| 8710077 |
Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
Oliver Plettenburg, Jochen Goerlitzer, Matthias Löhn, Sandrine Biscarrat, Frederic Jeannot +1 more |
2014-04-29 |
$11,952,000 |
| 8541449 |
Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors |
Oliver Plettenburg, John Weston, Matthias Loehn, Heinz-Werner Kleemann, Olivier Duclos +1 more |
2013-09-24 |
$21,313,000 |
| 8524737 |
Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
Oliver Plettenburg, Matthias Loehn, Olivier Duclos, Sandrine Biscarrat |
2013-09-03 |
$19,666,000 |
| 8399482 |
6-substituted isoquinolines and isoquinolinones |
Oliver Plettenburg, Matthias Loehn, John Weston, Heinz-Werner Kleemann |
2013-03-19 |
$17,899,000 |